NASDAQ:DMAC - DiaMedica Therapeutics News Headlines

$3.65
-0.26 (-6.65 %)
(As of 07/22/2019 08:55 AM ET)
Today's Range
$3.60
Now: $3.65
$3.89
50-Day Range
$2.61
MA: $3.93
$4.99
52-Week Range
$2.46
Now: $3.65
$5.93
Volume66,522 shs
Average Volume74,832 shs
Market Capitalization$43.65 million
P/E RatioN/A
Dividend YieldN/A
Beta2.77

Headlines

DiaMedica Therapeutics (NASDAQ DMAC) News Headlines

Source:
DateHeadline
 Brokerages Set $12.07 Price Target for DiaMedica Therapeutics Inc (NASDAQ:DMAC) Brokerages Set $12.07 Price Target for DiaMedica Therapeutics Inc (NASDAQ:DMAC)
www.americanbankingnews.com - July 18 at 12:11 PM
DiaMedica Therapeutics Inc (NASDAQ:DMAC) Sees Significant Increase in Short InterestDiaMedica Therapeutics Inc (NASDAQ:DMAC) Sees Significant Increase in Short Interest
www.americanbankingnews.com - July 11 at 7:42 PM
Protagonist Therapeutics (NASDAQ:PTGX) & DiaMedica Therapeutics (NASDAQ:DMAC) Head-To-Head SurveyProtagonist Therapeutics (NASDAQ:PTGX) & DiaMedica Therapeutics (NASDAQ:DMAC) Head-To-Head Survey
www.americanbankingnews.com - July 11 at 12:15 PM
Zacks: Brokerages Anticipate DiaMedica Therapeutics Inc (NASDAQ:DMAC) to Post -$0.28 Earnings Per ShareZacks: Brokerages Anticipate DiaMedica Therapeutics Inc (NASDAQ:DMAC) to Post -$0.28 Earnings Per Share
www.americanbankingnews.com - July 5 at 4:14 PM
Short Interest in DiaMedica Therapeutics Inc (NASDAQ:DMAC) Rises By 25.8%Short Interest in DiaMedica Therapeutics Inc (NASDAQ:DMAC) Rises By 25.8%
www.americanbankingnews.com - June 27 at 9:49 AM
AUY, HL among premarket gainersAUY, HL among premarket gainers
seekingalpha.com - June 20 at 11:47 AM
DiaMedica Therapeutics Announces Interim Results from Phase 1b Trial of DM199 in Chronic Kidney Disease ParticipantsDiaMedica Therapeutics Announces Interim Results from Phase 1b Trial of DM199 in Chronic Kidney Disease Participants
finance.yahoo.com - June 19 at 8:40 PM
DiaMedica Therapeutics to Present at the 16th Annual Craig-Hallum Institutional Investor ConferenceDiaMedica Therapeutics to Present at the 16th Annual Craig-Hallum Institutional Investor Conference
www.nasdaq.com - May 22 at 10:42 AM
DiaMedica Therapeutics Announces Formation of Scientific Advisory Board for Kidney DiseaseDiaMedica Therapeutics Announces Formation of Scientific Advisory Board for Kidney Disease
finance.yahoo.com - May 21 at 3:37 PM
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q1 2019 Results - Earnings Call TranscriptDiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 14 at 3:42 PM
DiaMedica Therapeutics Announces First Quarter 2019 Financial Results and Provides Business UpdateDiaMedica Therapeutics Announces First Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - May 14 at 7:16 AM
DiaMedica Therapeutics, Inc. to Host Earnings CallDiaMedica Therapeutics, Inc. to Host Earnings Call
finance.yahoo.com - May 14 at 7:16 AM
DiaMedica Therapeutics to Report First Quarter 2019 Financials and Provide an Update on DevelopmentDiaMedica Therapeutics to Report First Quarter 2019 Financials and Provide an Update on Development
www.nasdaq.com - May 6 at 9:40 AM
DiaMedica Therapeutics to Report First Quarter 2019 Financials and Provide an Update on Development Programs on May 14, 2019DiaMedica Therapeutics to Report First Quarter 2019 Financials and Provide an Update on Development Programs on May 14, 2019
finance.yahoo.com - May 6 at 9:40 AM
Diamedica Therapeutics Inc.Diamedica Therapeutics Inc.
www.barrons.com - March 23 at 8:56 AM
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q4 2018 Results - Earnings Call TranscriptDiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 20 at 3:28 PM
DiaMedica Therapeutics Announces 2018 Financial Results and Provides Corporate UpdateDiaMedica Therapeutics Announces 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - March 20 at 8:41 AM
DiaMedica Therapeutics Announces Date for the Release of Full Year 2018 Results and Conference CallDiaMedica Therapeutics Announces Date for the Release of Full Year 2018 Results and Conference Call
finance.yahoo.com - March 18 at 3:34 PM
DiaMedica Therapeutics to Attend 31st Annual ROTH Investor Conference on March 18-19, 2019DiaMedica Therapeutics to Attend 31st Annual ROTH Investor Conference on March 18-19, 2019
finance.yahoo.com - March 12 at 3:31 PM
DiaMedica Therapeutics Doses First Patient in Phase 1b Clinical Study of DM199 in Patients with Chronic Kidney DiseaseDiaMedica Therapeutics Doses First Patient in Phase 1b Clinical Study of DM199 in Patients with Chronic Kidney Disease
finance.yahoo.com - February 14 at 3:23 PM
DiaMedica Therapeutics Announces Publication of a Paper, “Human Tissue Kallikrein in the Treatment of Acute Ischemic Stroke,” in the Journal Therapeutic Advances in Neurological DisordersDiaMedica Therapeutics Announces Publication of a Paper, “Human Tissue Kallikrein in the Treatment of Acute Ischemic Stroke,” in the Journal Therapeutic Advances in Neurological Disorders
finance.yahoo.com - January 22 at 3:22 PM
The Daily Biotech Pulse: Cancer Genetics Prices Offering, DiaMedica Delists From Canadian Exchange, Medigus CEO QuitsThe Daily Biotech Pulse: Cancer Genetics Prices Offering, DiaMedica Delists From Canadian Exchange, Medigus CEO Quits
finance.yahoo.com - January 10 at 3:18 PM
DiaMedica Therapeutics Announces Voluntary Delisting from TSX Venture ExchangeDiaMedica Therapeutics Announces Voluntary Delisting from TSX Venture Exchange
finance.yahoo.com - January 10 at 6:30 AM
UPDATE -- DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney DiseaseUPDATE -- DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney Disease
globenewswire.com - January 3 at 3:18 PM
UPDATE - DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney DiseaseUPDATE - DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney Disease
finance.yahoo.com - January 3 at 3:18 PM
This page was last updated on 7/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel